4Moving Biotech

We are thrilled to announce that Professor @Larhumato will be attending the annual American College of Rheumatology conference hashtag#ACR from November 14 to 19. #ACR #Rheumatology #Osteoarthritis #Innovation #Research

4Moving Biotech a le plaisir d'annoncer sa participation à la 11e édition du « GALA Arthritis ». Une soirée organisée par la Fondation Arthritis, visant à soutenir l’émergence d’une recherche française de qualité sur les rhumatismes et maladies musculo-squelettiques. #biotech

We are thrilled to announce that Luc Boblet joins 4Moving Biotech as its Chief Executive Officer. Luc is a seasoned biotech entrepreneur with a demonstrated track record of building biotech ventures. To read the Press Release👉: businesswire.com/news/home/2024… #Biotech #4P004

Join us for the 18th Annual Conference of the International Society of OsteoArthritis Imaging, scheduled for Wednesday, June 26, 2024, in Marrocco! Professor @Larhumato, our Chief Medical Officer, will share his expertise on "Synovitis and OA Pain". #osteoarthritis #IWOAI

4Moving Biotech is delighted to announce successful results from its Lasare Phase I 4P004 Clinical Trial intraarticular Liraglutide for knee osteoarthritis patients. Read the Press release here: businesswire.com/news/home/2024… #osteoarthritis #4P004 #biotech #frenchtech

We are thrilled to announce that Professor @Larhumato, Chief Medical Officer of 4Moving Biotech, is invited to speak at the EULAR congress, which will take place from June 12 to 15 in Vienna. 🎙️Title of lecture: “ Disease-Modifying OA Drugs: Are We There Yet?” #EULAR2024

Félicitations à @4Moving_Biotech cofondée par Francis Berenbaum, Professeur de rhumatologie à @HopSaintAntoine, nommée l’une des « 100 Start-up où investir en 2024 » par le magazine @Challenges pour son innovation dans le traitement de l'#arthrose 👏

Félicitations à @4Moving_Biotech, nommée parmi les "100 start-up où investir en 2024” par @Challenges ! 👏👏 👉 Issue de la recherche académique, 4Moving Biotech a été cofondée par le professeur Francis Berenbaum (@Larhumato) et soutenue par @SATTLutech : challenges.fr/start-up/4movi…

[#OARSI2024] Our CMO, Professor @larumatho, will deliver an oral presentation on Friday, April 19, 2024, during the OARSI 2024 Clinical Trial Symposium. Coralie Meurot, our preclinical researcher scientist, will present her poster during the congress poster presentation session.

4Moving Biotech is pleased to announce its sponsorship of the Osteoarthritis Research Society International (OARSI) Congress in Vienna, Austria, April 18-21. #Biotech #4P004 #clinicaltrial #OARSI

4Moving Biotech wishes you an incredible year of 2024 filled with success, achievement, and unforgettable moments.

We are excited to be part of the 42nd Annual #JPMweek in San Francisco, US, from 8 to 10 January, 2024. Our CEO @rrattenbach and 4Moving Biotech Corporate Business Development, Luc Boblet are delighted to connect with you in person at the event. #biotech #pharma #4P004 #GLP1

4Moving Biotech sera présent au 36e congrès de la Société Française de Rhumatologie, du 10 au 12 décembre 2023 à la Porte de Versailles. Le Pr @Larhumato, notre Directeur médical partagera nos dernières avancées dans l'arthrose du genou. #Biotech #4P004 #Rhumatologie

Explore the insightful interview with our Chairwoman, Revital Rattenbach, on the Globaldata website! She discusses the significant milestones in 4Moving Biotech's clinical trial, our osteoarthritis asset. #Biotech #ClinicalTrials #Osteoarthritis #GlobalDataInterview

4Moving Biotech announces establishing an international Scientific Advisory Board in anticipation of its knee osteoarthritis drug candidate's phase 2b clinical trial. For more details: (lien) #biotech #liraglutide #4P004 #Osteoarthritis #firstinclass #GLP1

4Moving Biotech announces establishing an international Scientific Advisory Board in anticipation of its knee osteoarthritis drug candidate's phase 2b clinical trial. For more details: bwnews.pr/473utU8 #biotech #liraglutide #4P004 #Osteoarthritis #firstinclass #GLP1

[#GalaArthritis] Nous avons le plaisir de participer au « GALA Arthritis 2023 » le lundi 13 novembre au Pavillon Cambon, Paris. Une soirée organisée par la @FArthritis. #biotech #pharma #Arthrose #4P004 #musculosquelettiques #GalaArthritis2023 #rhumatismes

[#PrixGalienUS] Our company is honored to have been nominated in the “Best Startup” category for the 2023 #PrixGalienUS. #biotech #startup #BestStartup #osteoarthritis #GLP1 #liraglutideIntraarticualire #4P004 #frenchheathcare #PrixGalien

4Moving Biotech is thrilled to announce the successful completion of its Phase I recruitment clinical trial in patients with knee osteoarthritis. For more details: bit.ly/3tDPUfJ #4MovingBiotech #liraglutide #4P004 #Osteoarthritis #ClinicalTrials #Biotechnology

Pr. @Larhumato, our CEO/CMO, showcased a presentation entitled «Pioneering Innovation in Osteoarthritis Treatment for Patients» at CHINABio. It was a pleasure for us. #biotech #4P004 #Innovation #OsteoarthritisTreatment #CHINABio #4PPharma